Is ATOSSA THERAPEUTICS Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: ATOS) stock is to Strong Buy ATOS stock.
Similarly, Why is Atossa stock dropping?
What happened. Shares of Atossa Therapeutics ( ATOS -2.54% ) were tumbling 22.8% as of 11:36 a.m. EDT on Wednesday. The decline came after the company announced final results from its phase 2 clinical study evaluating oral endoxifen in treating breast cancer with administration between diagnosis and surgery.
Is ATOS a good buy? Maxim Group is very positive about ATOS and gave it a « Buy » rating on Sep 18, 2020. The price target was set to $8.00.
Thereof, Will Atossa Therapeutics stock go up?
Stock Price Forecast
The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 6.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +442.99% increase from the last price of 1.11.
Does ATOS recover?
Feb. 28, 2022, at 6:02 p.m. (Reuters) – Atos is entering « a pivotal year » after facing a series of setbacks in 2021, the head of the French IT consulting group said on Monday.
Why did ATOS stock go up?
What happened. Atossa Therapeutics ( ATOS -1.67% ) stock closed just over 20% higher on Tuesday. The surge was due to a modest but impactful price target raise from an analyst tracking the company.
Will ATOS be added to Russell 2000?
Atossa will be part of the Russell 2000 and Russell 3000 after the U.S. stock market opens on June 28.
Join TheMoney.co community and don’t forget to share this post !